百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

已收盘 12-29 16:08:54

34.900

-0.180

-0.51%

最高38.800	最低33.420	成交量644.89万
今开35.040	昨收35.080	日振幅15.34%
总市值156.00亿	流通市值38.74亿	总股本4.47亿
成交额2.34亿	换手率5.81%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":34.9,"timestamp":1766995734454,"preClose":35.08,"halted":0,"volume":6448946,"delay":0,"floatShares":111000000,"shares":447000000,"eps":0.093576272144273,"marketStatus":"已收盘","change":-0.18,"latestTime":"12-29 16:08:54","open":35.04,"high":38.8,"low":33.42,"amount":234061378,"amplitude":0.153364,"askPrice":34.9,"askSize":1000,"bidPrice":34.88,"bidSize":37000,"shortable":0,"etf":0,"ttmEps":0.369786947141358,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767058200000},"marketStatusCode":5,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":35.08,"openAndCloseTimeList":[[1766971800000,1766980800000],[1766984400000,1766995200000]],"volumeRatio":1.79708,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2595270060","title":"港股异动 | 百奥赛图-B(02315)涨超6%再创新高 公司已正式进入港股通 机构指千鼠万抗前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2595270060","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595270060?lang=zh_cn&edition=full","pubTime":"2025-12-29 09:54","pubTimestamp":1766973261,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B早盘涨超6%，高见37.28港元，再创上市新高。消息面上，近日，上交所与深交所公告，将百奥赛图-调入港股通股票名单，自2025年12月24日起生效。银河证券发布研报称，百奥赛图公司以基因编辑技术为基石，随着公司主要投入的千鼠万抗计划进入兑现期，公司业绩有望带来大幅增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK1161","BK0216","02315"],"gpt_icon":0},{"id":"1172346911","title":"异动解读 | 百奥赛图-B(02315)盘中大涨5.19%，获纳入港股通名单提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1172346911","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172346911?lang=zh_cn&edition=full","pubTime":"2025-12-29 09:36","pubTimestamp":1766972210,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)今日盘中大涨5.19%，市场表现强劲。消息面上，公司H股正式被纳入港股通股票名单，自2025年12月24日起生效。这一举措标志着百奥赛图-B向内地投资者全面开放，预计将显著提升股票流动性和交易活跃度，并吸引更多南向资金流入，推动公司价值重估。此外，百奥赛图-B近期业绩表现亮眼，2025年前三季度营业收入同比增长59.5%，归母净利润成功扭亏为盈，展现出良好的盈利能力和成长潜力。公司独特的“双引擎”平台化商业模式和技术护城河也进一步增强了市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"gpt_icon":0},{"id":"2595277564","title":"百奥赛图-B(02315)获纳入港股通名单 业绩高增驱动价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2595277564","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595277564?lang=zh_cn&edition=full","pubTime":"2025-12-29 08:54","pubTimestamp":1766969651,"startTime":"0","endTime":"0","summary":"近日，上交所与深交所公告，将百奥赛图-B调入港股通股票名单，自2025年12月24日起生效。回顾市场历史，纳入港股通往往是上市公司迎来价值重估的重要契机。凭借稀缺的商业模式、深厚的技术护城河和业绩面近期的显著利好，此次纳入港股通，将有望成为推动百奥赛图投资价值被二次重估的关键催化剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02315","BK1161","BK0216","688796"],"gpt_icon":0},{"id":"1102493660","title":"一周港股牛熊榜 | AI材料与有色爆发！中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%；因股份解禁，周六福暴跌24.9%、药捷安康暴跌20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493660","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102493660?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:46","pubTimestamp":1766738819,"startTime":"0","endTime":"0","summary":"24日镍概念集体走高，力勤资源、中伟新材、新疆新鑫矿业均涨幅近 9%。12月23日，周六福在港交所公告，董事会注意到公司H股价格近期出现不寻常波动。根据数据，此次药捷安康共计5名股东发生解禁，累计解禁股数达977.4万股，占比约2.46%。23日跌超18%、24日继续跌5.8%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03939","02315","02617","02579","02268","HSTECH","HSCEI","02068","06821","HSI","06168","02245","01952"],"gpt_icon":1},{"id":"2593471013","title":"智通港股解盘 | 晶圆涨价持续助推AI材料端 稀有资源镍矿集体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2593471013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593471013?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:51","pubTimestamp":1766577112,"startTime":"0","endTime":"0","summary":"备案文件显示，关税税率将至少提前 30 天公布。据其分析称，AI 服务器等产品电源芯片的大量需求占用 BCD 产能，是此次涨价主要行业因素，“暂不清楚未来其他晶圆厂是否会跟进涨价”。各种 AI 相关材料都在涨价，据报道，三星电子、SK 海力士等存储供应商已上调明年 HBM3E 价格，涨幅接近 20%。数据显示，此次越疆共计 36 名股东发生解禁，累计解禁股数约 1.93 亿股。公司2025 年第三季度营收 4.47 亿元，经调整净利润 0.65 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01812","688796","BK1526","06166","02315","BK1240","BK1551","BK1514","00826","02579","BK1553","BK0216","01117","BK4588","BK1237","BK1149","002703","BK0132","BK1179","BK1610","BK1223","02314","09858","SG9999014674.SGD","BK4213","03858","BK1161","BK0264","BK1116","02245","03833","BK1144","00148","GDP","02432","BK1163","VIS","02498","BK1170","BK4585","BK1607","00981","BK1225","BK1587","BK1183","BK1614","BK1212","BK1190","02689","01057"],"gpt_icon":1},{"id":"2593421364","title":"港股半日市窄幅震荡 半导体核电逆势走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2593421364","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593421364?lang=zh_cn&edition=full","pubTime":"2025-12-24 13:36","pubTimestamp":1766554560,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　港股速报 | 港股半日市窄幅震荡 半导体核电逆势走强。　　12月24日，受假期影响，港股迎来半日市，上午收盘后即完成全天交易。市场整体呈现窄幅震荡格局，板块分化特征显著，半导体、核电等板块逆势走强，航空股则持续承压。　　板块表现呈现明显分化，科技相关及能源类板块成为今日市场核心亮点。半导体板块强势上扬，成为半日市领涨主线之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-24/doc-inhcwnvp4495205.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-24/doc-inhcwnvp4495205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02315","BK4588","HSI","02878","01164","02302","HSTECH","SMH","01811","SOXX","688981","BK4585"],"gpt_icon":1},{"id":"2593344098","title":"百奥赛图-B(02315.HK)涨近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593344098","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593344098?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:49","pubTimestamp":1766540996,"startTime":"0","endTime":"0","summary":"每经AI快讯，百奥赛图-B(02315.HK)早盘涨近20%，截至发稿涨19.51%，报34.3港元，成交额2273.51万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512243600477911.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4ce77089c3dfea59728ed7854516af14","theme_name":"🔥热榜No.34 · 中芯国际及港股芯片股集体上涨及百奥赛图-B调入港股通","theme_type":2,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512243600477911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02315","BK0216","BK1161","688796"],"gpt_icon":0},{"id":"1199131778","title":"百奥赛图-B盘初快速拉升近20%！该公司获调入港股通标的证券名单，今日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1199131778","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199131778?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:32","pubTimestamp":1766539930,"startTime":"0","endTime":"0","summary":"12月24日，$百奥赛图-B(02315)$盘初快速拉升近20%！该公司获调入港股通标的证券名单，今日起生效。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1421e84be9d1e8ccf1d8f45413971ecf","theme_name":"🔥热榜No.47 · 百奥赛图-B调入港股通标的名单引发股价大幅上涨","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0216","02315"],"gpt_icon":0},{"id":"1128235938","title":"百奥赛图-B获调入港股通标的证券名单，12月24日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1128235938","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128235938?lang=zh_cn&edition=full","pubTime":"2025-12-24 08:43","pubTimestamp":1766536980,"startTime":"0","endTime":"0","summary":"12月24日，深交所：港股通标的证券名单调整，调入$百奥赛图-B(02315)$，12月24日起生效。","market":"hk","thumbnail":"https://static.tigerbbs.com/41a3265725dba67c0660b26a189585aa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/41a3265725dba67c0660b26a189585aa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1421e84be9d1e8ccf1d8f45413971ecf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百奥赛图-B获调入港股通标的证券名单，12月24日起生效","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","688796"],"gpt_icon":0},{"id":"2591362299","title":"依托全人抗体分子库+靶点人源化小鼠库双平台，手握充沛现金流的百奥赛图继续领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2591362299","media":"明大教主","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591362299?lang=zh_cn&edition=full","pubTime":"2025-12-15 10:37","pubTimestamp":1765766240,"startTime":"0","endTime":"0","summary":"02 抗体分子、靶点人源化小鼠两大平台行业领先，百奥赛图两项业务已构筑坚实壁垒创新药研发大致分为药物发现、临床前研究、临床试验、新药上市审批和上市后监测五个阶段。对此，百奥赛图拥有“源头抗体分子”、“靶点人源化小鼠”两大核心平台，可实现从抗体源头分子到体内验证的闭环加速，助力合作企业“一键成药”。靶点人源化小鼠平台。除百奥赛图外，国内也有其他公司能够提供抗体分子授权业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215105249a44c1672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215105249a44c1672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978","02315"],"gpt_icon":0},{"id":"2590575299","title":"港股异动 | 百奥赛图-B(02315)盘中涨超5% 公司成功登陆科创板 构建A+H双平台上市格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2590575299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590575299?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:37","pubTimestamp":1765525071,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B盘中涨超5%，截至发稿，涨4.15%，报28.12港元，成交额1950.98万港元。消息面上，12月10日，百奥赛图在上交所科创板挂牌上市。这是百奥赛图继2022年9月1日登陆香港交易所后，在深化资本市场布局、提升企业价值上又迈出的关键一步，标志着公司成功构建“H+A”双平台上市格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","688796","159982","02315"],"gpt_icon":0},{"id":"2590509062","title":"科创板挂牌后，百奥赛图“A+H” 双引擎欲推动中国创新药走向全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2590509062","media":"野马财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590509062?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:13","pubTimestamp":1765505596,"startTime":"0","endTime":"0","summary":"百奥赛图从上市到长期战略的逻辑延展。12月10日，公司在科创板成功上市，继2022年港交所挂牌后正式迈入“A+H”双地上市时代。这不仅是资本层面的突破，更象征着其“全人抗体库+靶点人源化小鼠库”双引擎体系从中国走向全球创新药产业的关键节点。2025年前三季度净利润达1.14亿元，经营净现金流进一步增长至2.63亿元。海外营收占比接近70%，表明百奥赛图的平台价值正加速被全球市场吸收，而不是局限在中国本土市场的波动之中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212101538a443a5b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212101538a443a5b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","02315","BK1161"],"gpt_icon":0},{"id":"2590254249","title":"百奥赛图-B12月11日遭主力抛售92.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590254249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590254249?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440935,"startTime":"0","endTime":"0","summary":"12月11日, 百奥赛图-B股价跌7.53%，报收27.00元，成交金额2059.8万元，换手率0.67%，振幅12.05%，量比0.61。百奥赛图-B今日主力资金净流出92.8万元，连续4日净流出，上一交易日主力净流出531.1万元。该股近5个交易日下跌12.85%，主力资金累计净流出1211.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2409.7万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161823a6990ad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161823a6990ad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2590584191","title":"百奥赛图-B(02315)12月10日发行4750万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590584191","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590584191?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:24","pubTimestamp":1765369446,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B(02315)发布公告，于2025年12月10日发行4750万股A股;转换2.886亿股非上市股份为2.886亿股A股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","688796","159982","399300","02315"],"gpt_icon":0},{"id":"1180507970","title":"百奥赛图(688796)更新翌日披露报表，已发行A股增至3.36亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1180507970","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180507970?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:21","pubTimestamp":1765369276,"startTime":"0","endTime":"0","summary":"百奥赛图(北京)医药科技股份有限公司(股票代码：688796)于2025年12月10日发布翌日披露报表，公告显示公司已发行股份发生变动。\n公告称，公司通过A股发行及非上市股份转换，共新增47,500,000股A股，另有288,616,500股非上市股份转换为同等数量的A股，转换日期同为2025年12月10日。发行价格每股人民币26.68元。本次发行完成后，该公司A股数量增至336,116,500股，非上市股份则降至0股。\n公司同时确认，上述发行及转换均已履行相关上市规则及法律程序，并经公司董事会正式授权。公告由联席公司秘书王永亮签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"gpt_icon":0},{"id":"2590539201","title":"百奥赛图今日上市 发行价格26.68元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539201","media":"IT桔子","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590539201?lang=zh_cn&edition=full","pubTime":"2025-12-10 18:08","pubTimestamp":1765361290,"startTime":"0","endTime":"0","summary":"百奥赛图是一家以稳定、高效基因编辑技术平台为依托，以模式动物定制服务、重要模式动物开发与规模化繁殖与供应、体内药理药效评价服务、抗体药物研发外包服务为一体的高科技生物医药企业。拥有基因编辑平台、模式动物繁殖与供应平台、药理药效平台、抗体药物研发服务平台。百奥赛图今日在上海证券交易所科创板上市，公司证券代码为688796，发行价格26.68元/股，发行市盈率为519.12倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210181157a72f885a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210181157a72f885a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2590302362","title":"【券商聚焦】西部证券首予百奥赛图(02315)“买入”评级 后续分子进一步临床推进 平台价值有望进一步放大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590302362","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590302362?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:20","pubTimestamp":1765354802,"startTime":"0","endTime":"0","summary":"公司于2020年3月率先启动“千鼠万抗”计划，“抗体货架”模式，一方面节省了研发时间并降低了早期研发的不确定性，另一方面通过源头平行比较多个靶点，有望协助药企提高研发效率及临床转化的成功率。随着后续分子进一步临床推进，公司平台价值有望进一步放大。首次覆盖，给予“买入”评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","02315","002673"],"gpt_icon":0},{"id":"2590539734","title":"百奥赛图-B12月10日遭主力抛售531.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590539734?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354506,"startTime":"0","endTime":"0","summary":"12月10日, 百奥赛图-B股价跌11.52%，报收29.20元，成交金额1.1亿元，换手率3.54%，振幅24.91%，量比7.17。百奥赛图-B今日主力资金净流出531.1万元，连续3日净流出，上一交易日主力净流出194.0万元。该股近5个交易日下跌4.81%，主力资金累计净流出1118.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2013.3万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161519953532f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161519953532f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2590539202","title":"百奥赛图：抗体业务收入增长，获“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539202","media":"和讯网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590539202?lang=zh_cn&edition=full","pubTime":"2025-12-10 15:33","pubTimestamp":1765352025,"startTime":"0","endTime":"0","summary":"【12月10日，西部给予百奥赛图“买入”评级】百奥赛图是创新技术驱动新药研发的国际生物公司，旨在成全球新药发源地。其基于底层基因编辑技术，自研RenMice平台，可用于多种抗体发现。 公司临床前产品和服务增长快，全球化运营获海外MNC认证，实现规模化动物模型销售。“千鼠万抗”货架模式提升开发效率，抗体授权推动业绩弹性。 公司抗体业务始于2020年，当年收入0.41亿元，2025年上半年达1.63亿元。随着分子临床推进，平台价值有望放大。此次为首次覆盖，给予“买入”评级。本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210172618a72f6feb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210172618a72f6feb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2590130349","title":"百奥赛图-B(02315)大跌18.48% A股百奥赛图(688796)上海科创板首挂暂升136.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590130349","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590130349?lang=zh_cn&edition=full","pubTime":"2025-12-10 14:07","pubTimestamp":1765346826,"startTime":"0","endTime":"0","summary":"金吾财讯 | 百奥赛图-B(02315)股价大幅走低，创逾1个月低位，截至发稿，报26.9港元，跌18.48%，成交额6745.89万港元。A股百奥赛图(688796)今日上海科创板首日挂牌，暂升136.17%，报63.01元人民币，当前H股价格对A股折让61.49%。百奥赛图预计2025年营收为13.51亿元，同比增幅约为37.75%；预计扣非净利润约8027万元，较上年同期变动幅度约为249.50%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971287","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","02315","BK1161","399300","688796"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.3618},{"period":"1month","weight":0.0728},{"period":"3month","weight":0.1892},{"period":"6month","weight":0.5488},{"period":"1year","weight":3.0981},{"period":"ytd","weight":3.1271}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要提供抗体药物研发和临床前研究服务的中国公司。该公司运营五个分部。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物，亦向客户授出若干模式动物的许可。抗体开发分部识别有潜力成为候选药物的抗体，并就潜在治疗性抗体分子对外授权或与合作伙伴合作。创新药开发分部研发创新药，专注肿瘤学和自身免疫性疾病治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.105956},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052338},{"month":3,"riseRate":0.333333,"avgChangeRate":0.185414},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066586},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.135934}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}